MedTrace Logo

Effect of Desmopressin on the Nocturnal Micturition Frequency in Patients With Parkinson Disease

NCT00806468 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2010-12-20

No results posted yet for this study

Summary

This study will be conducted to study the effect of Desmopressin on the nocturnal micturition frequency in patients with idiopathic Parkinson syndrome.

Conditions

  • Parkinson Disease

Interventions

DRUG

Desmotabs

Desmotabs encapsulated, 0,2 mg once daily for one week, 0,2 mg bid for one week

Sponsors & Collaborators

  • Johannes Gutenberg University Mainz

    lead OTHER

Principal Investigators

  • Thomas Vogt, MD · Johannes Gutenberg University Mainz, Department of Neurology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2010-12-31
Completion
2011-02-28

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00806468 on ClinicalTrials.gov